Search
Sulprostone
go.drugbank.com/drugs/DB12708InvestigationalSulprostone has been used in trials studying Abortion, Induced.
Categories: Prostaglandins EEfineptakin alfa
go.drugbank.com/drugs/DB16395InvestigationalThis drug is currently being investigated in the areas of oncology, immunology, and infectious disease. … Compared to endogenous IL-7, NT-I7 is more stable and potent, has a longer half-life, and has better bioavailability.
Nigericin
go.drugbank.com/drugs/DB14056ExperimentalA polyether antibiotic which affects ion transport and ATPase activity in mitochondria. It is produced by Streptomyces hygroscopicus. (From Merck Index, 11th ed)
Categories: Compounds used in a research, industrial, or household settingEPC2407
go.drugbank.com/drugs/DB05189InvestigationalEPC2407 is a novel small molecule vascular disruption agent and apoptosis inducer for the treatment of patients with advanced solid tumors and lymphomas. It is intended for the treatment of advanced cancer patients with solid tumors that...
Oxaprotiline
go.drugbank.com/drugs/DB09307ExperimentalBoth enantiomers have antidepressant effects but levoprotiline also is an antihistamine and dextroprotiline has many other pharmacological actions. … This drug was never marketed. Oxaprotiline is a racemic mixture of the isomers levoprotiline and dextroprotiline. Levoprotiline is the R or levo isomer of oxaprotiline (CGP-12,103-A).
Cimicoxib
go.drugbank.com/drugs/DB05095InvestigationalIf approved, Cimicoxib would be the first drug in decades to treat depression by a new mechanism of action. … Cimicoxib is a selective COX-2 inhibitor being developed by Affectis as a treatment for depression and schizophrenia.
Human interferon omega-1
go.drugbank.com/drugs/DB05472InvestigationalIt has been investigated both in single and combination treatment. The biological activities of IFN-omega 1 and its physiological role are not known to date. … There are multiple routes for administration of omega interferon: injection, an implantable subcutaneous drug delivery system, and an oral formulation.
SC12267
go.drugbank.com/drugs/DB05125InvestigationalSC12267 is a novel, small molecule agent from the class of DMARDs (disease modifying anti-rheumatic drug) for the therapy of autoimmune diseases such as rheumatoid arthritis or multiple sclerosis.